Kang‐Yun Lee

ORCID: 0000-0003-4705-5802
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Air Quality and Health Impacts
  • Obstructive Sleep Apnea Research
  • Cancer Immunotherapy and Biomarkers
  • 3D Printing in Biomedical Research
  • Immune cells in cancer
  • Neuroscience of respiration and sleep
  • Neonatal Respiratory Health Research
  • Lung Cancer Treatments and Mutations
  • Asthma and respiratory diseases
  • Climate Change and Health Impacts
  • Sleep and related disorders
  • Cancer Cells and Metastasis
  • Ferroptosis and cancer prognosis
  • Lung Cancer Research Studies
  • Sleep and Work-Related Fatigue
  • Air Quality Monitoring and Forecasting
  • Microfluidic and Bio-sensing Technologies
  • Immune Response and Inflammation
  • Immunotherapy and Immune Responses
  • Microfluidic and Capillary Electrophoresis Applications
  • Respiratory Support and Mechanisms
  • Cardiovascular and Diving-Related Complications
  • Peptidase Inhibition and Analysis
  • Pediatric health and respiratory diseases

Taipei Medical University-Shuang Ho Hospital
2016-2025

Taipei Medical University
2015-2025

Royal Brompton Hospital
2023

Ministry of Health and Welfare
2023

Isabela State University
2023

Pulmonary Associates
2021

Brigham and Women's Hospital
2020

Cornell University
2020

Princeton University
2020

Federation of American Societies for Experimental Biology
2020

Abstract Background: Recent trials have demonstrated the clinical benefit of immunotherapy in either neoadjuvant or adjuvant resectable (R) NSCLC setting. AEGEAN (NCT03800134) is a randomized, double-blind, placebo (PBO)-controlled trial assessing durvalumab (D) + chemotherapy (CT) followed by surgery (Sx) and D patients (pts) with R-NSCLC. Methods: Adults treatment (Tx)-naïve R-NSCLC (stage II-IIIB[N2]; AJCC 8th ed) ECOG PS 0/1 were randomized (1:1) to receive 1500 mg PBO IV platinum-based...

10.1158/1538-7445.am2023-ct005 article EN Cancer Research 2023-05-29
Toby M. Maher Paul Ford Kevin M. Brown Ulrich Costabel Vincent Cottin and 95 more Sonye K. Danoff Irene Groenveld Eric Helmer Gisli Jenkins Julie Milner Geert Molenberghs Björn Penninckx Matthew J. Randall Bernt van den Blink Ann Fieuw Charlotte Vandenrijn Sanda Rocak Ineke Seghers Lixin Shao Amit Taneja Garrit Jentsch Timothy R. Watkins Wim Wuyts Michael Kreuter Nadia Verbruggen Niyati Prasad Marlies Wijsenbeek Daniel C. Chambers Michael Chia Tamera J. Corte Ian Glaspole Nicole Goh Mark Holmes M.A. Malouf Francis Thien Elizabeth Veitch Benjamin Bondue Caroline Dahlqvist Antoine Froidure Hans Slabbynck Wim Wuyts Claudia Cartagena Salinas Rosa Feijoó Seoane Victor D. Martínez Roxana Maturana Juana Pavie Gallegos Andrés Rosenblüt Rafael Silva Alvaro Undurraga Pereira Martina Doubková Norbert Pauk Martina Plačková Martina Šterclová Elisabeth Bendstrup Saher Burhan Shaker Ingrid Louise Titlestad Stephan Budweiser Christian Grohé Dirk Koschel Michael Kreuter Antje Prasse Michael Weber Hubert Wirtz Katerina M. Antoniou Zoe Daniil Mina Gaga Despoina Papakosta Shinyu Izumi Masaki Okamoto Alfredo Guerreros Benavides Carlos Barrera Alejandro Manuel Peña Villalobos Aranzazu Campo Ezquibela José Manuel Cifrián Estrella Fernández Fabrellas Virginia Leiro María Molina‐Molina Asunción Nieto Barbero Jacobo Sellarés Claudia Valenzuela Shih-Lung Cheng Ping‐Hung Kuo Kang‐Yun Lee Chau‐Chyun Sheu Hakan Günen Nesrin Moğulkoç Sibel Atış Naycı Huzaifa Adamali Stephen Bianchi Nazia Chaudhuri Michael Gibbons Simon P. Hart Philip L. Molyneaux Helen Parfrey Gauri Saini Lisa Spencer Sarah Wiscombe Danielle Antin‐Ozerkis Rebecca Bascom John A. Belperio

There is a major need for effective, well-tolerated treatments idiopathic pulmonary fibrosis (IPF).To assess the efficacy and safety of autotaxin inhibitor ziritaxestat in patients with IPF.The 2 identically designed, phase 3, randomized clinical trials, ISABELA 1 2, were conducted Africa, Asia-Pacific region, Europe, Latin America, Middle East, North America (26 countries). A total 1306 IPF (525 at 106 sites 781 121 2). Enrollment began November 2018 both trials follow-up was completed...

10.1001/jama.2023.5355 article EN JAMA 2023-05-09

Abstract Abnormal expression of TGF-β1 is believed to play an important role in the pathogenesis a number chronic inflammatory and immune lung diseases, including asthma, obstructive pulmonary disease, fibrosis. Gene activation eukaryotes requires coordinated use specific cell signals, chromatin modifications, remodeling. We studied roles ubiquitous transcription factors, NF-κB AP-1, gene histone acetylation at promoter. IL-1β-induced protein secretion mRNA were prevented by actinomycin D...

10.4049/jimmunol.176.1.603 article EN The Journal of Immunology 2006-01-01

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous family of myeloid that suppress T-cell immunity in tumor-bearing hosts. Their clinical relevance remains unclear.To identify subtypes myeloid-derived patients with non-small cell lung cancer (NSCLC) and their relevance.CD11b(+)CD14(-) CD11b(+)CD14(+) cells, determined phenotyped by fluorescence-activated sorter analysis, the peripheral blood mononuclear (PBMCs) treatment-naive advanced NSCLC were correlated data. activation...

10.1164/rccm.201204-0636oc article EN American Journal of Respiratory and Critical Care Medicine 2012-09-07

397600 Background: While PD-1 inhibitors demonstrated survival benefit compared to chemotherapy in patients (pts) with PD-L1-high, NSCLC, less than half of pts respond monotherapy. Novel therapeutics or combinations are necessary improve outcomes. Domvanalimab (D) is an Fc-silent humanized IgG1 monoclonal antibody (mAb) that blocks T cell Immunoglobulin and ITIM domain (TIGIT), thereby reducing immunosuppression T/NK cells promoting antitumor activity. Etrumadenant (E) a selective dual...

10.1200/jco.2022.40.36_suppl.397600 article EN Journal of Clinical Oncology 2022-10-20

Abstract Impaired lung function is associated with morbidity and mortality in the elderly. However, there a paucity of data regarding long-term effects particulate matter (PM) on among This study evaluated exposure-response relationship between ambient PM different indices elderly Taiwan. A cross-sectional survey individuals aged ≥65 years was conducted Taiwan from October 2015 to September 2016. Those who attended annual health examination for five hospitals varying background...

10.1038/s41598-019-51307-5 article EN cc-by Scientific Reports 2019-10-15

Lung cancer (LC) causes the majority of cancer-related deaths. Circular RNAs (circRNAs) were reported to play roles in cancers by targeting pro- and anti-oncogenic miRNAs. However, mechanisms circRNAs LC progression their prognostic value treatment response remain unclear. By using next generation sequencing (NGS) cell lines' transcriptomes, we identified highly overexpressed hsa_circ_0000190 hsa_circ_000164 as potential biomarkers. sensitive RT-ddPCR method, these shown be secreted lines...

10.3390/cancers12071740 article EN Cancers 2020-06-30

Lung cancer is the most commonly diagnosed worldwide, and metastasis in lung leading cause of cancer-related deaths. Thus, understanding mechanism will improve diagnosis treatment patients. Herein, we found that expression cluster differentiation 109 (CD109) was correlated with invasive metastatic capacities adenocarcinoma cells. CD109 upregulated tumorous tissues, overexpression associated tumor progression, distant metastasis, a poor prognosis patient adenocarcinoma. Mechanistically,...

10.1111/cas.14373 article EN cc-by-nc-nd Cancer Science 2020-03-05

Abstract Expression of the inflammatory chemokine, growth-related oncogene protein-α (GRO-α), from airway smooth muscle cells (ASMC) is regulated by pathways involving NF-κB and MAPK activation. We determined effects dexamethasone on GRO-α induced IL-1β or TNF-α with respect to role phosphatase-1 (MKP-1). Human ASMC were studied in primary culture at confluence. Dexamethasone (10−8–10−5 M) partially inhibited expression release TNF-α; this was associated an inhibition JNK, but not p38 ERK...

10.4049/jimmunol.178.11.7366 article EN The Journal of Immunology 2007-06-01

Long-term exposure to air pollution can lead cardiovascular disease, metabolic syndrome, and chronic respiratory disease. However, from a lifetime perspective, the critical period of in terms health risk is unknown. This study aimed evaluate impact at different life stages. The participants were recruited community centers Northern Taiwan between October 2018 April 2021. Their annual averages for fine particulate matter (PM2.5) derived national visibility database. Lifetime PM2.5 exposures...

10.1016/j.envres.2023.115957 article EN cc-by-nc-nd Environmental Research 2023-04-20

Abstract Adenosine is a potent endogenous regulator of airway inflammation that acts through specific receptor subtypes can either cause constriction (A1R, A2BR, and A3R) or relaxation (A2AR) the airways. We therefore examined effects key inflammatory mediators on expression A2AR in lung epithelial cell line (A549). IL-1β TNF-α increased gene at mRNA protein levels. In contrast, LPS had no effect expression. rapidly activated p50 p65, but not C-Rel, RelB, p52, both IL-1β- TNF-α-stimulated...

10.4049/jimmunol.177.10.7173 article EN The Journal of Immunology 2006-11-15

Abstract Loss of skeletal muscle mass is common with aging and can cause morbidity mortality in the elderly. The effects particulate air pollution on not known. study aims to assess chronic ambient fine particulates (PM 2.5 ) body composition From October 2015 November 2016, a cross-sectional survey 530 elderly (age > = 65 years) was conducted Taipei Basin, Taiwan. measured by bioelectrical impedance analysis (InBody 120). One year exposure estimated using Kriging method at participant’s...

10.1038/s41598-019-47576-9 article EN cc-by Scientific Reports 2019-08-01

Non-small cell lung cancer (NSCLC) patients harboring a KRAS mutation have unfavorable therapeutic outcomes with chemotherapies, and the also renders tolerance to immunotherapies. There is an unmet need for new strategy overcoming immunosuppression in KRAS-mutant NSCLC. The recently discovered role of melatonin demonstrates wide spectrum anticancer impacts; however, effect on modulating tumor immunity largely unknown. In present study, treatment significantly reduced viability accompanied by...

10.3390/ijms22115649 article EN International Journal of Molecular Sciences 2021-05-26

Acute respiratory distress syndrome (ARDS) contributes to higher mortality worldwide. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have immunomodulatory and regenerative potential. However, the effects of hUC-MSCs as an ARDS treatment remain unclear. We investigated role in differentiation type II alveolar epithelial (AECII) by regulating Yes-associated protein (YAP) ARDS. Male C57BL/6JNarl mice were intratracheally (i.t.) administered lipopolysaccharide (LPS) induce model,...

10.1016/j.biopha.2023.114302 article EN cc-by Biomedicine & Pharmacotherapy 2023-01-25

Background: Silver nanoparticles (AgNPs) have been associated with the exacerbation of asthma; however, immunological basis for adjuvant effects AgNPs is not well understood. Objective: The aim study reported here was to investigate allergic AgNP inhalation using proteomic approaches. Methods: Allergen provoked mice were exposed 33 nm at 3.3 mg/m 3 . Following this, bronchoalveolar lavage fluid (BALF) and plasma collected determine protein profiles. Results: In total, 106 79 AgNP-unique...

10.2147/ijn.s46997 article EN cc-by-nc International Journal of Nanomedicine 2013-08-01
Coming Soon ...